1.
Kinos S, Hagman H, Halonen P, Soveri L-M, O’Reilly M, Pfeiffer P, et al. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study). AO [Internet]. 2024 May 2 [cited 2026 May 1];63(1):248-5. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24023